BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.15% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.66% |
| 4 | Healthcare | 5.15% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Magnachip Semiconductor
MX
$137M
| $37.4K | ﹤0.01% |
2,212
+2,172
| +5,430% | +$39K |
|
3427
EverQuote
EVER
$864M
| $36.7K | ﹤0.01% |
2,268
-50,257
| -96% | -$761K |
|
3428
First Bank
FRBA
$471M
| $36.7K | ﹤0.01% |
2,579
-3,871
| -60% | -$55.6K |
|
3429
Cue Biopharma
CUE
$131M
| $36.1K | ﹤0.01% |
247
-463
| -65% | -$98.2K |
|
3430
Omega Flex
OFLX
$291M
| $36.1K | ﹤0.01% |
278
-552
| -67% | -$77K |
|
3431
Hooker Furnishings Corp
HOFT
$158M
| $36K | ﹤0.01% |
1,902
-2,982
| -61% | -$63.5K |
|
3432
Tilly's
TLYS
$122M
| $35.8K | ﹤0.01% |
3,820
-6,039
| -61% | -$74.4K |
|
3433
Capital Southwest
CSWC
$1.61B
| $35.6K | ﹤0.01% |
1,500
-2,000
| -57% | -$49K |
|
|
NVO
3434
Novo Nordisk
NVO
$205B
| $35.5K | ﹤0.01% |
640
| – | – |
|
3435
Utah Medical Products
UTMD
$230M
| $35.4K | ﹤0.01% |
394
-845
| -68% | -$77.7K |
|
|
CMLS
3436
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $35.4K | ﹤0.01% |
3,554
-644
| -15% | -$6.84K |
|
3437
Geron
GERN
$982M
| $35.3K | ﹤0.01% |
25,951
-77,953
| -75% | -$86.9K |
|
|
TBCH
3438
Turtle Beach Corp
TBCH
$230M
| $35.2K | ﹤0.01% |
1,655
-1,702
| -51% | -$35.6K |
|
3439
Citizens
CIA
$198M
| $34.9K | ﹤0.01% |
8,230
-13,024
| -61% | -$58.9K |
|
|
YMAB
3440
DELISTED
Y-mAbs Therapeutics
YMAB
| $34.8K | ﹤0.01% |
2,928
-6,172
| -68% | -$63.4K |
|
3441
Stoke Therapeutics
STOK
$2.02B
| $34.6K | ﹤0.01% |
1,645
-2,426
| -60% | -$48.6K |
|
3442
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $34.5K | ﹤0.01% |
231
-513
| -69% | -$75.9K |
|
3443
CorMedix
CRMD
$639M
| $34.4K | ﹤0.01% |
6,284
-8,362
| -57% | -$38.3K |
|
3444
Evolution Petroleum
EPM
$135M
| $34.4K | ﹤0.01% |
5,071
+5,069
| +253,450% | +$32.6K |
|
|
IEA
3445
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $34.4K | ﹤0.01% |
2,902
-8,098
| -74% | -$86.8K |
|
3446
Comscore
SCOR
$91.6M
| $34.1K | ﹤0.01% |
586
-934
| -61% | -$53.5K |
|
|
ALPN
3447
DELISTED
Alpine Immune Sciences Inc
ALPN
| $33.9K | ﹤0.01% |
3,777
+531
| +16% | +$4.59K |
|
3448
Pure Cycle
PCYO
$273M
| $33.9K | ﹤0.01% |
2,817
-3,237
| -53% | -$40.1K |
|
|
CLSD
3449
DELISTED
Clearside Biomedical
CLSD
| $33.5K | ﹤0.01% |
975
| – | – |
|
|
SPNE
3450
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $33.4K | ﹤0.01% |
2,748
-5,983
| -69% | -$72.8K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.